KREBS BIOCHEMICALS & INDUSTRIES
Back to Cashflow Statement
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹13 Cr | ₹5.50 Cr | ₹37 Cr | ₹40 Cr | ₹38 Cr |
What is the latest Cash Flow from Financing Activities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹5.50 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹38 Cr |
How is Cash Flow from Financing Activities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 133.78 | |
| Mar2024 | ₹5.50 Cr | -85.26 | |
| Mar2023 | ₹37 Cr | -5.48 | |
| Mar2022 | ₹40 Cr | 4.90 | |
| Mar2021 | ₹38 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹126.8 Cr | -1.3% | 24.8% | -28.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,332.0 Cr | 4.7% | -0.3% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,800.0 Cr | 2.3% | 6.8% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.5% | -1.7% | 26.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,075.0 Cr | 11.3% | 7.6% | 12.5% | Stock Analytics | |
| CIPLA | ₹105,662.0 Cr | 5.9% | 7.3% | -14.1% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | -1.3% |
24.8% |
-28.2% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses